Skip to main content

Table 3 The association between inositol intake and lipid profiles based on subgroup analysis

From: The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials

Variables

Number of SMD included

Subgroups

Pooled OR (random effect)

95% CI

I2 (%)

Overall I2 (%)

Triglycerides

Type of disease

5

PCOS

−0.74

−1.66, 0.18

91.7

93.2

7

Non-PCOS

−1.58

−2.32, −0.85

92.1

Dosage of inositol (mg/day)

6

≥2000

−0.83

−1.49, − 0.18

83.4

6

<2000

−1.69

−2.69, −0.68

96.2

Duration of study (week)

5

≥14

−1.64

−2.94, −0.34

93.4

7

<14

−0.99

−1.67, − 0.32

93.1

Type of intervention

4

DCI

−0.32

−0.66, 0.01

0.0

6

MI

−1.15

−1.91, −0.39

94.0

2

MI + DCI

−3.37

−6.00, −0.75

94.2

Total cholesterol

Type of disease

5

PCOS

−0.86

−1.72, − 0.02

90.3

93.6

6

Non-PCOS

−1.49

−2.51, −0.46

95.5

Dosage of inositol (mg/day)

5

≥2000

−0.82

−1.91, 0.28

92.2

6

<2000

−1.51

−2.38, −0.63

95.2

Duration of study (week)

5

≥14

−1.77

−3.31, −0.22

95.0

6

<14

−0.74

−1.33, − 0.15

90.5

Type of intervention

4

DCI

−0.22

−0.62, 0.18

26.2

5

MI

−0.91

−1.59, − 0.24

91.9

2

MI + DCI

−3.76

−5.68, −1.85

88.2

LDL-cholesterol

Type of disease

3

PCOS

−0.60

−1.51, 0.31

86.1

92.2

2

Non-PCOS

−1.84

−3.41, 0.26

93.1

Dosage of inositol (mg/day)

3

≥2000

−0.86

−2.27, 0.54

93.2

2

<2000

−2.00

−3.98, −0.03

94.8

Duration of study (week)

4

≥14

−1.39

−2.78, −0.01

94.0

1

<14

−1.03

− 1.37, −0.70

0.0

Type of intervention

2

DCI

−0.15

− 0.61, 0.30

0.0

1

MI

−1.03

−1.37, −0.70

–

2

MI + DCI

−2.59

−3.39, −1.81

56.7

HDL-cholesterol

Type of disease

3

PCOS

0.38

0.12, 0.64

2.4

89.4

7

Non-PCOS

0.14

−0.56, 0.84

92.7

Dosage of inositol (mg/day)

5

≥2000

0.01

−0.59, 0.62

81.1

5

<2000

0.37

−0.31, 1.04

92.2

Duration of study (week)

4

≥14

−0.61

−1.35, 0.14

83.5

6

<14

0.68

0.42, 0.95

55.1

Type of intervention

3

DCI

0.19

−0.17, 0.55

0.0

5

MI

0.72

0.42, 1.02

62.0

2

MI + DCI

−1.22

−1.73, −0.71

36.2

  1. MI myo-inositol, DCI D-chiro-Inositol, PCOS polycystic ovary syndrome